DexCom ( NASDAQ:DXCM ) First Quarter 2024 Results Key Financial Results Revenue: US$921.0m (up 24% from 1Q 2023). Net...
Dexcom stock plunged Friday after the company raised its sales outlook for the year, but not enough to satisfy investors.
DexCom's (DXCM) first-quarter 2024 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.